Abivax Income Statement (2021-2025) | ABVX

Income Statement Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.03M5.88M13.63M10.76M-32.19M7.03M5.94M91.74M
Operating items
Research & Development -38.83M-31.13M-47.54M271.92M-41.34M-43.74M-64.78M
Selling, General & Administrative -8.84M-10.55M-8.10M62.25M-8.45M-9.36M-29.81M
Other Operating Expenses -2.15M-2.42M-0.94M11.80M-0.90M-0.76M-2.15M
Operating Expenses -49.82M-44.10M-56.57M345.97M-50.69M-53.87M-96.75M
Operating Income -48.53M-38.04M-55.12M-45.73M-49.65M-52.63M-94.36M
EBIT -48.53M-38.04M-55.12M-45.73M-49.65M-52.63M-94.36M
Non-operating items
Interest & Investment Income 6.55M3.89M3.77M4.04M-1.08M3.96M23.85M
Non Operating Income 1.96M-3.71M-5.53M3.66M-5.44M-2.17M-84.93M
Net income details
EBT -46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Profit After Tax -158.96M46.57M41.75M60.65M-334.58M55.09M-114.08M-297.11M
Income from Continuing Operations -46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Consolidated Net Income -46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Income towards Parent Company -46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Net Income towards Common Stockholders -46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Additional items
EPS (Basic) -0.68-0.03M-0.87-0.62-0.06M-0.03M-2.10
EPS (Weighted Average and Diluted) -0.06M-0.03M-0.87-0.62-0.06M-0.76-2.10
Shares Outstanding (Weighted Average) 17.68M19.48M46.34M68.35M0.00M69.44M67.37M873.060.00M85.28M
Shares Outstanding (Diluted Average) 17.68M19.48M46.34M738.730.00M69.44M67.37M873.0671.81M85.28M
EBITDA -48.53M-38.04M-55.12M-45.73M-49.65M-52.63M-94.36M
Interest Expenses -4.59M-7.60M-9.31M35.92M-7.07M-6.13M-108.78M